Shares of Abbott Laboratories fell 2.85% to $106.8 in premarket trading Wednesday although the company beat second-quarter earnings and sales estimates, fueled by sales of its COVID-19 tests. In the second quarter of 2022 Abbott reported earnings of $2.018 billion, or $1.14 per share, compared to earnings of $1.189 billion, or 66 cents a share, in the same period last year. Adjusted earnings per share were $1.43, compared to a FactSet consensus of $1.13 a share. Abbott reported revenue of...


Become a member to take advantage of more features, like commenting and voting.

Jobs to Watch